Sentences with phrase «pharmacogenomics at»

Since 2013, he serves as Associate Professor of Pharmacogenomics at the University of Patras (Greece).

George P. Patrinos currently serves as Associate Professor of Pharmacogenomics at the University of Patras (Greece), and since 2010, as expert and Greece's National representative at the CHMP Pharmacogenomics Working Party of the European Medicines Agency (London, UK).

A recent study of a new course in pharmacogenomics at Washington State University Spokane found the class expanded students» understanding of these possibilities for their profession.

Not exact matches

I continued working at the interface of science and epidemiology, first with Genaissance Pharmaceuticals, a New Haven - based pharmacogenomics company, where I was involved in the fascinating study of human genetic variation and population genetics.

One current study looks at the pharmacogenomic profile of asthma patients and healthy controls, and these data will serve as a reference database for future studies.

Drug companies were much in evidence at the convention, and if there is one area of genomics that has attracted a critical mass of believers, it's pharmacogenomics.

Results of this study has shown that there is a significant inter-population variability, as far as pharmacogenomic biomarker allele frequency is concerned, which has a direct impact on the rationalization of drug use at a population level.

The Silvio O. Conte Center, a multi-institutional effort based at the University of Chicago, will combine the statistical power of pre-existing genetics, pharmacogenomics, text - mining, and clinical record databases to confront diseases that have so far frustrated researchers.

It is expected that pharmacogenomics is most likely cost - effective, since it reduces the incidence of adverse drug reactions, which can reciprocally reduce healthcare expenditure at the national level.

Pharmacogenomic tests have the potential to improve resource allocation by improving targeting of treatments so that individuals at risk of having adverse responses to medications or not responding to medications can avoid them, thereby reducing healthcare costs.